Skip to content

Clinical trials

Observational Macular Degeneration trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Country / region: France Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20101
20111
20131
20152
20172
20184
20192
20204
20212
20221
20232
20241
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Unknown status4
Terminated3
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondation Ophtalmologique Adolphe de Rothschild5
Bayer3
Centre Hospitalier Intercommunal Creteil2
Centre Hospitalier Universitaire Dijon2
Institut National de la Santé Et de la Recherche Médicale, France2
Medical University of Vienna2
Nantes University Hospital2
Association for Innovation and Biomedical Research on Light and Image1
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1
Centre Hospitalier Universitaire, Amiens1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration33
Retinal Vein Occlusion4
Macular Edema3
Choroidal Neovascularization2
Geographic Atrophy2
Hypertension2
Parkinson Disease2
Retinal Degeneration2
Retinal Dystrophies2
Anetoderma1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.